Dr. Susan Anton has been appointed director of Epidemiology and Risk Management Practice, ICON Late Phase & Outcomes Research. Dr. Anton has more than 25 years of experience leading international epidemiologic, health economic, and outcomes research, and other market access initiatives. She joins the company from Boehringer Ingelheim, where she was director of U.S. Medical Outcomes Research and Registries. Prior to BI, Dr. Anton directed health economic, epidemiologic and outcomes research e...